End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
129.6 CNY | -0.28% | -7.08% | -4.47% |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- With an expected P/E ratio at 32.47 and 24.26 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.47% | 2.49B | - | ||
+3.47% | 103B | A- | ||
-8.02% | 61.43B | A- | ||
+72.86% | 49.09B | B | ||
+15.48% | 38.46B | B | ||
+3.64% | 32.09B | A- | ||
+13.29% | 20.39B | B- | ||
+12.53% | 16.78B | C+ | ||
+15.34% | 14.76B | B- | ||
+0.39% | 13.73B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688281 Stock
- Ratings Shaanxi Huaqin Technology Industry Co.,Ltd.